gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects; D001693:Biological Transport, Active; D018756:GABA Antagonists; D006801:Humans; D007700:Kinetics; D001523:Mental Disorders / Q000503:physiopathology; D009422:Nervous System Diseases / Q000503:physiopathology; D018377:Neurotransmitter Agents; D013569:Synapses / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism / Q000502:physiology*
D000700:Analgesics; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D018756:GABA Antagonists; D018377:Neurotransmitter Agents; D005680:gamma-Aminobutyric Acid